RIO DE JANEIRO, BRAZIL - Amid concerns that Brazil will interrupt the vaccination campaign for lack of doses, researchers from two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.
The agreement would serve to conduct phase 3 trials in Brazil between June and July this year. Subsequently, the Finnish universities would provide the technology transfer (teach step by step) for the manufacture of the immunizer in Brazil - the same type of agreement that was signed by the Butantan Institute with SinoVac and the Oswaldo Cruz Foundation (Fiocruz) with . . .